This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a trifluorobenzophenone moiety, is often incorporated into compounds designed to interact with specific receptors in the brain, such as serotonin or dopamine receptors. Additionally, the 1,4-dioxa-8-azaspiro[4.5]decyl group enhances the molecule's stability and bioavailability, making it valuable in the design of drugs with improved pharmacokinetic properties. Researchers also explore its potential in creating novel therapeutics for conditions like anxiety, depression, and neurodegenerative diseases.